Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease
Crossref DOI link: https://doi.org/10.1186/s12890-017-0372-z
Published Online: 2017-01-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burgel, Pierre-Régis https://orcid.org/0000-0003-0903-9828
Le Gros, Vincent
Decuypère, Laurent
Bourdeix, Isabelle
Perez, Thierry
Deslée, Gaëtan
Funding for this research was provided by:
Novartis Pharma AG